DiviDrip · STXS

STXS — Stereotaxis, Inc.

STXS is Stereotaxis, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $1.38. Market cap: $137M. Capital Quality Rank: 38/100 — Stagnant mediocrity.

Stock snapshot

Price$1.38
Market cap$137M
SectorHealthcare
ExchangeASE
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)38 / 100 · Stagnant mediocrity
ROIC (TTM)-329.6%
Revenue CAGR (3y)4.8%
Altman Z-score zoneDistress

About STXS

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Listed2004Employees131HQSt.Louis, MOSectorHealthcareWebsitestereotaxis.com

Related non-dividend companies

Other non-dividend stocks investors research alongside STXS. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is STXS's current stock price?

STXS (Stereotaxis, Inc.) is currently trading at $1.38.

Does STXS pay a dividend?

STXS (Stereotaxis, Inc.) does not currently pay a regular dividend.

What is STXS's Capital Quality Rank?

STXS has a Capital Quality Rank of 38/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track STXS in DiviDrip

Add STXS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow